Font Size




Menu Style

Michael Ison, Northwestern University, USA

Dr. Michael Ison obtained his medical degree at the University of South Florida College of Medicine and then completed his Internal Medicine Residency and General Internal Medicine Fellowship at Oregon Health Sciences University in Portland, Oregon.  He then obtained his Master of Science in Health Evaluation Sciences and did his Infectious Diseases Fellowship at the University of Virginia.  During his fellowship, he was mentored by Drs. Fredrick Hayden, Larisa Gubareva, and Tom Brachiale.  His research focused on the immunopathogenesis of influenza and its treatment in immunosuppressed and hospitalized patients.  He developed an immunocompromised mouse model of influenza to study the development of antiviral resistance.  In addition, he completed studies of the pharmacokinetics and outcomes of treatment with oseltamivir, zanamivir, and rimantidine in hospitalized patients.  After leaving the University of Virginia, he undertook additional training in Transplant Infectious Diseases at the Massachusetts General Hospital and Harvard Medical School under the mentorship of Dr. Jay A. Fishman.  He then joined the faculty of the Divisions of Infectious Diseases and Organ Transplantation at Northwestern University Feinberg School of Medicine in 2005. He is currently the Medical Director of the Transplant & Immunocompromised Host Infectious Diseases Service, Northwestern University Comprehensive Transplant Center.


He has continued to be a leader in the respiratory viruses research arena.  He has been the first author of the only two prospective interventional studies in hospitalized patients as well as a lead investigator for studies to determine how to prevent and treat  influenza in immunocompromised patients.  He has recently provided advice to the President’s H1N1 Subcommittee, NIH, and BARDA on issues related to influenza in hospitalized and immunocompromised patients. Additionally, he is considered an expert in adenovirus infections in immunosuppressed patients. 


In addition, he is heavily involved in other research and leadership positions in the Transplant Infectious Diseases arena and has been a member and is the current chair of the Advisory Committee on Blood Safety and Availability. From 2006-10 he chaired the United Network for Organ Sharing’s Disease Transmission Advisory Committee. He was recently elected as one of the At Large representatives on the OPTN/UNOS Board of Directors and member of the American Society of Transplantation Board of Directors.  He has also been involved globally as the chair of the Infectious Diseases Editorial Group for the CNT/WHO Project NOTIFY Library and the leader of the Infectious Diseases group of the World Health Organization Bologna Initiative on Global Vigilance and Surveillance.



Back to isirv-AVG Committee